Latest News

Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke

The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New guideline advises when to treat a first seizure

  • Extending natalizumab up to 8 weeks shown safe and effective in patients with multiple sclerosis, report says

  • PTSD common in ICU Survivors

  • Frequent indoor tanning among teens shows correlation with smoking, social media use

  • Autism-epilepsy connection explored in four studies

  • Video games in care homes: connecting older adults, or exposing age-related vulnerability?

  • Reducing global tobacco use

  • A new path to English language learning

  • New tactic targets brain tumors

  • Drugs stimulate body?s own stem cells to replace the brain cells lost in multiple sclerosis

  •